VHLA family alliance weekend. Great turnout and event co-hosted by our strong UCLA Clinical Care Center @UCLAHealth @UclaUrology @UCLAStrokeNSG
VHL Alliance Family Weekend in LA cohosted with @UCLAHealth Honored to sponsor our VHL center, one of the largest in the US! It takes a village and we have a great team of clinicians at UCLA to help patients thrive. @UclaUrology @IsaacYangMD
What a great event and a special trip to London! #EAU26
What should urologist know about rare renal tumors? Brian Shuch giving @UroOnc lecture at #EAU26. Insights on the variety of renal tumors with implications for prognosis and choice of systemic therapies. @UclaUrology
RIP Bernie Churchill- a giant in urology and co-author of seminal paper describing the RADICAL NEPHRECOMY! The best surgical coach one could have circlingthenews.com/obituary…
pubmed.ncbi.nlm.nih.gov/5765…
Brian Shuch, MD retweeted
In the latest episode of The UroOnc Minute, host Adam B. Weiner, MD, (@Adam_Weiner535) is joined by Brian M. Shuch, MD, (@KidneyCancerDoc) for a concise yet wide-ranging update on the evolving role of adjuvant therapy for renal cell carcinoma.
Check out the full discussion🎙️: urologytimes.com/view/the-ur…
Amazing meeting and event
Happy to fight for treatment against good friend @drphil_urology #uclakcp #DSUIOnTheBeach26 @UclaUrology
Brian Shuch, MD retweeted
Surveillance or early intervention? Drs. Pierorazio and Shuch debate kidney cancer management and share insights on when to monitor versus treat.
Key Takeaways:
✔️ The rate of M+RCC for non-growing SRM is zero.
✔️ Clear-cell RCC is predicted to grow faster than other histologic subtypes.
✔️ Delayed intervention is safe.
#DSUIOnTheBeach26
Great day. Big turnout of 250 people!
Hats off to @katy_beckermann & @KidneyCancerDoc for planning out a TRULY multi-D #kidneycancer @UroOnc course! Tremendous advocates (@advocatekidneys @salvolarosa), med oncs (@DrRanaMcKay @TiansterZhang @BradMcG04 @DrVaishampayan @HHammersMD @ZakhariaYousef), rad oncs (@ChadTangMD), pathologists (@drmehrarohit @PayalKapur5 @rovingatuscap) & the best RCC surgeons in the room all here!
The future is bright!
@KidneyCancer
I am so grateful for the opportunity to be a part of the KCA mentorship academy. An incredible experience through which I have learned so much! Extra thanks to my amazing mentors @KidneyCancerDoc and Jose Karam!
We all stand on the shoulders of giants, hoping the next generation will surpase us! Couldn’t be possible without the efforts of the @KidneyCancer team.
🧡 Inspiring to lead into #IKCSNA25 with mentors and mentees gathered for the KCA Mentorship Academy/Nizar Tannir Rare Kidney Cancer Scholar Program.
Congratulations to the new class, so proud of our inaugural mentees, grateful to the generous mentors!
Brian Shuch, MD retweeted
#ASTRO25 has a second dedicated session to #radiotherapy in #kidneycancer ! 😍 Amongst eminent friends and colleagues @ChadTangMD @NicholasZaorsky @DrRanaMcKay @KidneyCancerDoc @Raquib_Hannan @AnnA25_03 🥰 #radon
Brian Shuch, MD retweeted
Huge honor to present our work & receive the Outstanding Contributor to the Kidney Cancer field award at the meeting @MountsinaiUro . Thanks so much Dr Kyprianou for this honor. Even more special to receive this in presence of my dear friend @KidneyCancerDoc. @InnovateUpstate
Brian Shuch, MD retweeted
RENEGADE: Open-label, prospective, multi-center, phase 1/2 safety trial of theraspheres for localized RCC
@KidneyCancerDoc
Y90 glass microspheres for 400 Gy dose!
Opened 12/1/24
#SUO24 @urotoday
Great catching up with old friends including my former teammate (Michigan ultimate frisbee 1996-8) and former KCA Andy novick award winner for his 20 years of amazing work @cancerdrlane #ikcs2024
Happy to play a small role in an amazing organization
So great to see you @KidneyCancerDoc thank you for your leadership on our board and Medical Steering Committee! #IKCSNA24
Start of day 2 at the #ikcs2024 with the leadership dream team
@GEVaughan1 @salvolarosa @KidneyCancer
Brian Shuch, MD retweeted
Amazing to have @rschilsky, head of #TAPUR & fmr @ASCO president/CMO, kicking off the @KidneyCancer Mentorship Academy. Hats off to @salvolarosa & the terrific team for helping us generate a terrific program! Have enjoyed developing the program w @KidneyCancerDoc, @TiansterZhang & @eric_facs. Our first class of fellows is phenomenal (@NazliDizman, @WesleyYipMD, @may_alley, @minaseconomides et al). Grateful to #NizarTannirMD for establishing the #RareKidneyCancerScholarProgram w @PavlosMsaouel!
Great opportunity from a great organization! @KidneyCancer
⭐ APPLY TODAY for two unique mentorship programs! ⭐
Get guidance and education from the best #kidneycancer clinical & research leaders to take your careers to the next level!
Application deadline Sept 30 - Learn more, & apply now!
bit.ly/3yZgYsV
RT @TelixPharma: TLX250-CDx has not received a marketing authorisation in any jurisdiction. Zircaix brand name is subject to final regulato…
Paper out- TLX-250cdx as a tool to help patients with renal masses! also excited to have high risk postop staging protocol open too (Canine). @UclaUrology @UCLAJCCC @KidneyCancer @kcCURE @kidneycan @KidneyCancer_Ca @SUO_YUO
thelancet.com/journals/lanon…
clinicaltrials.gov/study/NCT…






































